.Nature Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint calls for incorporation of patients with MASLD and measurement of liver end results in cardio-- kidney-- metabolic tests, when information propose mechanistically tenable benefits and also professional safety and security-- as well as describes considerations for trial design and governing commendation.